Navigation Links
Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
Date:9/4/2007

NEW YORK, Sept. 4 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) announced the results of a controlled clinical trial, published in the September 2007 issue of the Journal of Clinical Hypertension, which demonstrated that nebivolol, a selective beta 1-blocker with vasodilating properties, significantly reduced sitting diastolic and systolic blood pressure among patients with mild-to-moderate hypertension. The study - the first to evaluate the drug in a U.S. population - also found that nebivolol was well tolerated in comparison to placebo and was not associated with adverse changes in blood glucose levels. Nebivolol is currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of hypertension.

"Next-generation beta blockers, such as nebivolol, represent a step forward in the treatment of hypertension," said Robert J. Weiss, M.D., Director Cardiovascular Research, Maine Clinical Research. "As we saw in the study, nebivolol demonstrated efficacy with a low incidence of side effects typical of traditional beta blockers, such as fatigue, erectile dysfunction, and depression. In addition, there were no clinically significant changes in glucose levels, which makes nebivolol useful in patients with certain metabolic disorders."

In the double-blind, placebo-controlled study, a total of 909 patients were randomized to receive placebo (81 patients) or nebivolol (828 patients) dosed at 1.25mg, 2.5mg, 5mg, 10mg, 20mg or 40mg once daily for up to 12 weeks. The 40mg dose was included to study safety only. The study concluded that nebivolol, at doses of 1.25mg to 20mg once daily, significantly reduced both trough sitting diastolic and systolic blood pressure. Additionally, the
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure as Long-Term Monotherapy and in Combination Therapy
2. Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
3. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
4. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
5. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
6. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
7. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
8. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
9. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
10. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
11. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 2014   Easy Breathe , the fastest growing online ... Blog " - has received more than 4.5 million unique page ... are thrilled that so many people are finding our blog and ... Breathe. "We,re committed to making sleep apnea more widely known and ... about sleep apnea news , troubleshooting advice , and ...
(Date:8/20/2014)... YORK, Aug 20, 2014 Reportlinker.com announces ... in its catalogue: Global Patient Scales ... This report analyzes the worldwide markets for ... Product Segments: Floor Scales, Infant & Baby Scales, ... provides separate comprehensive analytics for the US, Canada, ...
(Date:8/20/2014)... SAN MARCOS, Texas , Aug. 20, 2014 ... purchase of five diverse sets of patent families ... and major innovation driver for Bayer AG of ... The patents acquired provide broad intellectual property ... achieved in economical high-volume quantum dot (QD) manufacturing. ...
Breaking Medicine Technology:Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 2Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 3Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 4
... Inc. (OTC Bulletin Board: SCLR ) today ... and Drug Administration (FDA) identifying deficiencies regarding its Abbreviated ... The Company said the letter identified a number ... of the bioequivalence study submitted by SCOLR to support ...
... DIEGO, March 11, 2011 Conatus Pharmaceuticals Inc. today announced ... trial data of CTS-1027 for the treatment of hepatitis C ... Association for the Study of the Liver (EASL) to be ... 2011. Specifically, abstract 562 entitled: 24-WEEK TREATMENT WITH ...
Cached Medicine Technology:SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application 2Conatus Pharmaceuticals Will Display HCV Clinical Trial Data at the International Liver Congress™ (EASL) in March 2
(Date:8/21/2014)... August 21, 2014 While golfing in ... it hard to stay focused on his game due ... The constant whine, slapping and continual need to spray ... methods to stay protected from insects while golfing. He ... in the Financial Services/Investment Banking Industry, decided to change ...
(Date:8/21/2014)... Atlantic Information Services, Inc. (AIS) — industry-leading ... The AIS Report on Blue Cross & Blue Shield ... Association or its member companies) — is pleased to ... Management Insight Series. Bundled Payment Models: Bottom-Line Strategies ... — Horizon Healthcare Services, Inc. and Arkansas Blue Cross ...
(Date:8/21/2014)... San Diego, CA (PRWEB) August 21, 2014 ... website daily regarding all the latest information from the ... Solution . , The US FDA announced on August ... Peritoneal Dialysis Solution with 2.5% Dextrose 5000mL (Ambu-Flex II), ... to the presence of particulate matter. , The ...
(Date:8/21/2014)... Sometimes you have to lose the life of your dreams ... to a Hundred: Finding My Purpose through My Pain,” Jason Roy, ... broken family, a childhood of gang violence and two life-altering car ... to be,” Roy said. “I didn’t give up on God when ... today of helping others overcome their trials.” , He said his ...
(Date:8/21/2014)... August 21, 2014 OpsAssure, the ... start-ups selected to participate in the Harbor Accelerator's ... mentorship, curriculum sessions and valuable resources.he Harbor’s goal ... the region. Each start-up selected for the program ... order to help businesses grow quickly, test markets ...
Breaking Medicine News(10 mins):Health News:Financial VP Fights Pesky Bugs with Launch of Biteback Sports Insect Shield® Golf Apparel 2Health News:New AIS Report Highlights Two Case Studies of Bundled Payment Models 2Health News:Dianeal Low Calcium (2.5mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose 5000mL (Ambu-Flex II) Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Zero to a Hundred: True Story of Escaping Death to Meet Life 2
... , , OAKLAND, Calif. , Jan. 13 ... have responded in less than one day to the call by ... assistance to residents of earthquake devastated Haiti —leading the ... support these efforts with donations of funds to support travel costs ...
... ... ... 2010 -- Connextions Inc. today announced the appointment of Kenneth A. Burdick ... with an outstanding record of management and fiscal performance with the nation’s most respected ...
... , KIRKLAND, Wash. , Jan. 13 Long term ... Lifetime Television,s Balancing Act show. Denise Gott , the featured expert, ... term care for our loved ones. "Three in four will eventually need ... (LTCFP), one of America,s most experienced long term care insurance ...
... , ... the trusted leader in acne treatment for 15 years, today ... revolutionized the treatment of acne now enhanced with exclusive micro-crystal ... to penetrate even clogged pores quickly is the first change ...
... surgeons say , WEDNESDAY, Jan. 13 (HealthDay News) -- ... coaxed a donor trachea to grow its own network ... for months in the recipient,s arm. , The innovative ... trachea (windpipe), but it did so without the need ...
... treatment, researcher says, , WEDNESDAY, Jan. 13 (HealthDay News) -- ... turn cancerous. , At issue is how mutations occur in ... Jan. 13 in Nature , researchers report that cancer-causing ... , "The bad news is that it is much easier ...
Cached Medicine News:Health News:National Conference Call Thursday for 1,500 RN Volunteers for Haiti Relief Effort 2Health News:Veteran Health Insurance Senior Executive Joins Connextions Inc. Board of Directors 2Health News:Veteran Health Insurance Senior Executive Joins Connextions Inc. Board of Directors 3Health News:Long Term Care Insurance Expert Featured on Lifetime Television's Balancing Act Show 2Health News:Proactiv(R) Introduces New Micro-Crystal Technology and Unprecedented Customer Access to Expert Acne Treatment Advice 2Health News:Proactiv(R) Introduces New Micro-Crystal Technology and Unprecedented Customer Access to Expert Acne Treatment Advice 3Health News:Proactiv(R) Introduces New Micro-Crystal Technology and Unprecedented Customer Access to Expert Acne Treatment Advice 4Health News:Proactiv(R) Introduces New Micro-Crystal Technology and Unprecedented Customer Access to Expert Acne Treatment Advice 5Health News:Transplanted Trachea Grows Own Blood Supply in Patient's Arm 2Health News:Transplanted Trachea Grows Own Blood Supply in Patient's Arm 3
Angled 45 degree shafts 8 mm long with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Heavy curved shafts with 2 x 2 teeth and crisscross serrated 6 mm tying platform. Serrated handle with polished finish....
Straight shafts with teeth and 6 mm crisscross serrated tying surfaces. Serrated handle with polished finish....
Straight shafts with 1 x 2 teeth and serrated handle with polished finish....
Medicine Products: